What is the prevalence of Stevens Johnson Syndrome?

Stevens-Johnson Syndrome (SJS) is a rare, acute, and potentially life-threatening skin reaction with an estimated annual incidence ranging from 1 to 6 cases per million people worldwide.

Epidemiology and Distribution

Because Stevens-Johnson Syndrome is an acute, reactive condition rather than a chronic disease, clinicians typically measure its frequency through incidence (new cases per year) rather than prevalence (total people living with it). While Stevens-Johnson Syndrome can affect individuals of any age, it is more commonly observed in adults than in children. Regarding gender, data from the NIH GARD indicates that females are slightly more likely to be affected by Stevens-Johnson Syndrome than males, though the reasons for this disparity remain a subject of ongoing research.

Geographic and Genetic Factors

There is significant geographic and ethnic variation in how patients experience Stevens-Johnson Syndrome. This is largely tied to specific human leukocyte antigen (HLA) genetic markers. For example, individuals of Southeast Asian descent may have a higher genetic predisposition to developing Stevens-Johnson Syndrome when exposed to certain medications like carbamazepine or allopurinol. Consequently, prevalence rates are higher in regions where these specific genetic markers are more common.

Data Challenges and Real-World Perspectives

Accurate statistics for Stevens-Johnson Syndrome are notoriously difficult to capture. Because the condition is often triggered by medication and may be misdiagnosed as other dermatological or viral conditions in its early stages, many cases go unreported. Furthermore, the severity of the disease means that patients are often treated in acute burn units or intensive care settings, which can lead to fragmented data collection. At DiseaseMaps.org, our community of 294 members provides a vital, real-world perspective that complements traditional clinical literature, highlighting the diverse patient journeys and long-term recovery experiences that are often missing from standard epidemiological reports.

Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Stevens-Johnson Syndrome


• Orphanet: Epidermal Necrolysis (Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis)


• PubMed/NCBI: Global incidence and clinical patterns of Stevens-Johnson syndrome